Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study

For treating multidrug-resistant tuberculosis (MDR TB), the World Health Organization (WHO) recommends a regimen of at least four second-line drugs that are likely to be effective as well as pyrazinamide. WHO guidelines indicate only marginal benefit for regimens based directly on drug susceptibilit...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	PLoS medicine Ročník 12; číslo 12; s. e1001932
Hlavní autori:	Yuen, Courtney M., Kurbatova, Ekaterina V., Tupasi, Thelma, Caoili, Janice Campos, Van Der Walt, Martie, Kvasnovsky, Charlotte, Yagui, Martin, Bayona, Jaime, Contreras, Carmen, Leimane, Vaira, Ershova, Julia, Via, Laura E., Kim, HeeJin, Akksilp, Somsak, Kazennyy, Boris Y., Volchenkov, Grigory V., Jou, Ruwen, Kliiman, Kai, Demikhova, Olga V., Vasilyeva, Irina A., Dalton, Tracy, Cegielski, J. Peter
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Public Library of Science 01.12.2015 Public Library of Science (PLoS)
Predmet:	Adolescent Adult Aged Aged, 80 and over Antibiotics Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Care and treatment Clinical Protocols Clinical trials Cohort Studies Drug resistance Drug Therapy, Combination - statistics & numerical data Global Health Humans Microbial Sensitivity Tests Middle Aged Multidrug resistant organisms Mycobacterium - drug effects Proportional Hazards Models Prospective Studies Sputum - microbiology Tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy Young Adult
ISSN:	1549-1676, 1549-1277, 1549-1676
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!